*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter - as a primary diagnosis code | T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 5.69 | |
| Readmission Rate (%) | 22.27 | |
| Unplanned Readmission Rate (%) | NA | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|
| Total Hospitalizations at DRG | 71,748 | |
| Total Hospitalizations with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 28 | |
| DRG Share of Total Hospitalizations | 0.22 | |
| % of Total ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter in DRG | 58.33 | |
| Avg LOS at DRG | 2.93 | |
| Avg LOS with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 4.04 | |
| Readmission Rate at DRG | 33.86 | |
| Readmission Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | NA | |
| Unplanned Readmission Rate at DRG | 10.34 | |
| Unplanned Readmission Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | NA | |
| Total Medicare payments at DRG | $313,351,773 | |
| Total Medicare payments with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $110,400 | |
| Total Medicare payment per Day at DRG | $1,489 | |
| Total Medicare payment per Day with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $977 | |
| Total Medicare payment per Hospitalization at DRG | $4,367 | |
| Total Medicare payment per Hospitalization with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $3,943 | |
| Total Medicare Charges at DRG | $1,750,048,705 | |
| Total Medicare Charges with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $653,845 | |
| Avg Charges at DRG | $24,392 | |
| Avg Charges with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $23,352 | |
| Mortality Rate at DRG | 0.22 | |
| Mortality Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | NA | |
| SNF Discharge Rate at DRG | 7.61 | |
| SNF Discharge Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | NA | |
| Home Discharge Rate at DRG | 51.88 | |
| Home Discharge Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 57.14 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 092: OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 885: PSYCHOSES | DRG 091: OTHER DISORDERS OF NERVOUS SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 312: SYNCOPE AND COLLAPSE | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 122,730 | ||||
| Total Hospitalizations with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 632 | ||||
| DRG Share of Total Hospitalizations | 0.37 | ||||
| % of Total ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter in DRG | 7.73 | ||||
| Avg LOS at DRG | 7.61 | ||||
| Avg LOS with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 3.99 | ||||
| Readmission Rate at DRG | 21.31 | ||||
| Readmission Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 22.68 | ||||
| Unplanned Readmission Rate at DRG | 14.13 | ||||
| Unplanned Readmission Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 13.91 | ||||
| Total Medicare payments at DRG | $1,397,885,220 | ||||
| Total Medicare payments with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $3,649,680 | ||||
| Total Medicare payment per Day at DRG | $1,497 | ||||
| Total Medicare payment per Day with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $1,448 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,390 | ||||
| Total Medicare payment per Hospitalization with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $5,775 | ||||
| Total Medicare Charges at DRG | $4,175,290,309 | ||||
| Total Medicare Charges with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $18,268,335 | ||||
| Avg Charges at DRG | $34,020 | ||||
| Avg Charges with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $28,906 | ||||
| Mortality Rate at DRG | 0.28 | ||||
| Mortality Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 21.64 | ||||
| SNF Discharge Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 32.28 | ||||
| Home Discharge Rate at DRG | 28.06 | ||||
| Home Discharge Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 33.07 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 093: OTHER DISORDERS OF NERVOUS SYSTEM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 644: ENDOCRINE DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 160,950 | ||||
| Total Hospitalizations with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 354 | ||||
| DRG Share of Total Hospitalizations | 0.49 | ||||
| % of Total ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter in DRG | 4.33 | ||||
| Avg LOS at DRG | 4.98 | ||||
| Avg LOS with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 3.52 | ||||
| Readmission Rate at DRG | 20.85 | ||||
| Readmission Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 20.88 | ||||
| Unplanned Readmission Rate at DRG | 13.4 | ||||
| Unplanned Readmission Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 12.65 | ||||
| Total Medicare payments at DRG | $1,184,949,733 | ||||
| Total Medicare payments with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $1,711,116 | ||||
| Total Medicare payment per Day at DRG | $1,477 | ||||
| Total Medicare payment per Day with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $1,372 | ||||
| Total Medicare payment per Hospitalization at DRG | $7,362 | ||||
| Total Medicare payment per Hospitalization with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $4,834 | ||||
| Total Medicare Charges at DRG | $4,222,078,897 | ||||
| Total Medicare Charges with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $8,744,761 | ||||
| Avg Charges at DRG | $26,232 | ||||
| Avg Charges with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $24,703 | ||||
| Mortality Rate at DRG | 0.67 | ||||
| Mortality Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 22.29 | ||||
| SNF Discharge Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 28.81 | ||||
| Home Discharge Rate at DRG | 35.46 | ||||
| Home Discharge Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 31.07 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 643: ENDOCRINE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 365,119 | ||||
| Total Hospitalizations with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 180 | ||||
| DRG Share of Total Hospitalizations | 1.11 | ||||
| % of Total ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter in DRG | 2.2 | ||||
| Avg LOS at DRG | 5.91 | ||||
| Avg LOS with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 4.54 | ||||
| Readmission Rate at DRG | 27.73 | ||||
| Readmission Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 19.64 | ||||
| Unplanned Readmission Rate at DRG | 20.3 | ||||
| Unplanned Readmission Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 14.29 | ||||
| Total Medicare payments at DRG | $3,552,910,533 | ||||
| Total Medicare payments with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $1,551,685 | ||||
| Total Medicare payment per Day at DRG | $1,646 | ||||
| Total Medicare payment per Day with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $1,897 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,731 | ||||
| Total Medicare payment per Hospitalization with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $8,620 | ||||
| Total Medicare Charges at DRG | $16,860,985,198 | ||||
| Total Medicare Charges with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $5,768,663 | ||||
| Avg Charges at DRG | $46,179 | ||||
| Avg Charges with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $32,048 | ||||
| Mortality Rate at DRG | 5.06 | ||||
| Mortality Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 28.7 | ||||
| SNF Discharge Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 37.78 | ||||
| Home Discharge Rate at DRG | 32.16 | ||||
| Home Discharge Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 28.33 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 947: SIGNS AND SYMPTOMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 884: ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 474,314 | ||||
| Total Hospitalizations with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 118 | ||||
| DRG Share of Total Hospitalizations | 1.44 | ||||
| % of Total ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter in DRG | 1.44 | ||||
| Avg LOS at DRG | 3.53 | ||||
| Avg LOS with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 3.67 | ||||
| Readmission Rate at DRG | 18.03 | ||||
| Readmission Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 21.24 | ||||
| Unplanned Readmission Rate at DRG | 12.55 | ||||
| Unplanned Readmission Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 17.7 | ||||
| Total Medicare payments at DRG | $2,312,733,090 | ||||
| Total Medicare payments with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $632,307 | ||||
| Total Medicare payment per Day at DRG | $1,380 | ||||
| Total Medicare payment per Day with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $1,460 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,876 | ||||
| Total Medicare payment per Hospitalization with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $5,359 | ||||
| Total Medicare Charges at DRG | $11,559,952,314 | ||||
| Total Medicare Charges with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $2,838,889 | ||||
| Avg Charges at DRG | $24,372 | ||||
| Avg Charges with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | $24,058 | ||||
| Mortality Rate at DRG | 0.22 | ||||
| Mortality Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 25.96 | ||||
| SNF Discharge Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 34.75 | ||||
| Home Discharge Rate at DRG | 43.58 | ||||
| Home Discharge Rate with ICD T43215A - Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter | 29.66 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| CHRISTIANA CARE WILMINGTON HOSPITAL | 501 W 14TH ST | WILMINGTON | DE | 19801 | 35 |
| BAYSTATE MEDICAL CENTER | 759 CHESTNUT ST | SPRINGFIELD | MA | 01199 | 28 |
| ST. LUKE'S UNIVERSITY HOSPITAL - BETHLEHEM CAMPUS | 801 OSTRUM ST | BETHLEHEM | PA | 18015 | 25 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. MUHAMMAD MAHMOOD ALAM | 1019 E WATER ST | ELMIRA | NY | 14901 | 11 |